CytoMed Therapeutics
CytoMed Therapeutics Logo
About CytoMed Therapeutics
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company based in Singapore, focused on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases. The company’s lead programs include gamma delta T cell and natural killer cell-based 'off-the-shelf' immunotherapeutics, as well as induced pluripotent stem cell (iPSC) derived therapies. Founded in 2018 as a spin-off from Singapore’s Agency for Science, Technology and Research (A*Star), CytoMed aims to engineer innovative and affordable cellular therapies targeting a broad spectrum of solid and hematological cancers.
Address
1 Commonwealth Lane, No. 08-22,
Singapore, 149544
Singapore
Year founded
2018
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
